Description
AltretamineisananticancerchemotherapeuticagentthatbindsDNAatguanineandcytosineresidues,formingDNAadducts.Thisalkylatingagentisalsometabolizedtoformaldehyde.Altretamineisclinicallyusedtotreatovariancancer.
AltretamineisananticancerchemotherapeuticagentthatbindsDNAatguanineandcytosineresidues,formingDNAadducts.Thisalkylatingagentisalsometabolizedtoformaldehyde.Altretamineisclinicallyusedtotreatovariancancer.
CasNo. | 645-05-6 |
---|---|
Purity | ≥98% |
Formula | C9H18N6 |
FormulaWt. | 210.28 |
ChemicalName | N,N,N",N",N"",N""-Hexamethyl-1,3,5-triazine-2,4,6-triamine |
IUPACName | 2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine |
Synonym | HMM;Hexalen;Hexamethylmelamine |
MeltingPoint | 172-174°C |
Solubility | Practicallyinsolubleinwater.SolubleinDMSO. |
Appearance | WhiteCrystalPowder |
StoreTemp | 4°C |
---|---|
ShipTemp | Ambient |
MSDS | A4578MSDSPDF |
---|---|
InfoSheet | A4578InfoSheetPDF |
ChanJK,LoizziV,ManettaA,etal.Oralaltretamineusedassalvagetherapyinrecurrentovariancancer.GynecolOncol.2004Jan;92(1):368-71.PMID:14751188.
ColeyHM,BrooksN,PhillipsDH,etal.TheroleoftheN-(hydroxymethyl)melaminesasantitumouragents:mechanismofactionstudies.BiochemPharmacol.1995May11;49(9):1203-12.PMID:7763301.
HansenLA,HughesTE.Altretamine.DICP.1991Feb;25(2):146-52.PMID:1905441.